loading
Connect Biopharma Holdings Ltd Adr stock is traded at $1.83, with a volume of 121.75K. It is up +5.78% in the last 24 hours and down -23.11% over the past month. Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
See More
Previous Close:
$1.73
Open:
$1.77
24h Volume:
121.75K
Relative Volume:
0.80
Market Cap:
$101.97M
Revenue:
-
Net Income/Loss:
$-21.38M
P/E Ratio:
-4.6923
EPS:
-0.39
Net Cash Flow:
$-25.19M
1W Performance:
-10.73%
1M Performance:
-23.11%
6M Performance:
+110.32%
1Y Performance:
+81.19%
1-Day Range:
Value
$1.71
$1.84
1-Week Range:
Value
$1.60
$2.0788
52-Week Range:
Value
$0.51
$2.86

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile

Name
Name
Connect Biopharma Holdings Ltd Adr
Name
Phone
858-727-1040
Name
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Name
Employee
62
Name
Twitter
Name
Next Earnings Date
2024-04-16
Name
Latest SEC Filings
Name
CNTB's Discussions on Twitter

Compare CNTB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CNTB
Connect Biopharma Holdings Ltd Adr
1.83 106.99M 0 -21.38M -25.19M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-12-25 Initiated H.C. Wainwright Buy
Mar-04-24 Initiated H.C. Wainwright Buy
Apr-13-21 Initiated Jefferies Buy
Apr-13-21 Initiated Piper Sandler Overweight
Apr-13-21 Initiated SVB Leerink Outperform

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Latest News

pulisher
Aug 18, 2025

Connect Biopharma Posts Q2 Revenue Drop - AOL.com

Aug 18, 2025
pulisher
Aug 18, 2025

Q3 Earnings Estimate for CNTB Issued By Leerink Partnrs - Defense World

Aug 18, 2025
pulisher
Aug 16, 2025

HC Wainwright Cuts Earnings Estimates for Connect Biopharma - Defense World

Aug 16, 2025
pulisher
Aug 14, 2025

Connect Biopharma Reports Q2 Revenue Drop of 99.2% to $48,000, R&D Spending Increases 65.6% to $8.8mln - AInvest

Aug 14, 2025
pulisher
Aug 13, 2025

Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView

Aug 13, 2025
pulisher
Aug 13, 2025

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Aug 13, 2025
pulisher
Aug 06, 2025

Connect Biopharma Holdings Limited shares rise 5.63% after-hours following Jazz Pharmaceuticals' FDA approval of Modeyso. - AInvest

Aug 06, 2025
pulisher
Aug 01, 2025

Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN

Aug 01, 2025
pulisher
Jul 30, 2025

What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jul 30, 2025
pulisher
Jul 27, 2025

Research Analysts Set Expectations for CNTB Q2 Earnings - MarketBeat

Jul 27, 2025
pulisher
Jul 25, 2025

Connect Biopharma (NASDAQ:CNTB) Upgraded at Northland Capmk - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

Q2 Earnings Estimate for CNTB Issued By Northland Capmk - Defense World

Jul 25, 2025
pulisher
Jul 22, 2025

Connect Biopharma stock rating reiterated as Outperform by Northland - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Connect Biopharma appoints James A. Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Northland starts Connect Biopharma at Outperform on chance to define new class - TipRanks

Jul 22, 2025
pulisher
Jul 21, 2025

Connect Biopharma stock rises after announcing plan to terminate ADR program - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares By Investing.com - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to Terminate ADR Program and List Ordinary Shares on Nasdaq - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma Announces Plans to Terminate its American - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma Streamlines Trading: ADRs Convert to Direct Nasdaq Shares in Major US Market Push - Stock Titan

Jul 21, 2025
pulisher
Jul 18, 2025

Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire Inc.

Jul 18, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with minimum bid price rule - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with $1 minimum bid price - Investing.com

Jul 17, 2025
pulisher
Jul 11, 2025

Connect Biopharma Holdings shares rise 7.89% in after-hours after partner's new drug application for atopic dermatitis is accepted by NMPA. - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Connect Biopharma’s partner submits new drug application in China - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Connect Biopharma’s partner submits new drug application in China By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 08, 2025

Connect Biopharma (NASDAQ:CNTB) Trading Down 2.5% – Here’s What Happened - Defense World

Jul 08, 2025
pulisher
Jun 13, 2025

Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Connect Biopharma reports positive data for asthma treatment - Investing.com

Jun 13, 2025
pulisher
May 13, 2025

Connect Biopharma begins Phase 2 asthma study - Investing.com

May 13, 2025
pulisher
Apr 04, 2025

Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Apr 01, 2025

FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Connect Biopharma shares rise 1.62% after-hours following positive FDA feedback on Phase 2 trials for asthma and COPD treatments. - AInvest

Apr 01, 2025
pulisher
Mar 29, 2025

Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India

Mar 29, 2025
pulisher
Mar 28, 2025

Connect Biopharma faces Nasdaq delisting over share price - Investing.com

Mar 28, 2025
pulisher
Mar 27, 2025

Connect Biopharma stock hits 52-week low at $0.76 - Investing.com

Mar 27, 2025
pulisher
Feb 18, 2025

Connect Biopharma stock hits 52-week low at $0.91 amid market challenges - Investing.com India

Feb 18, 2025
pulisher
Jan 22, 2025

Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com

Jan 22, 2025

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):